<DOC>
	<DOCNO>NCT01171664</DOCNO>
	<brief_summary>To report compare total symptom score , nasal symptom score , post-nasal drip symptom score , adverse reaction SAR subject active drug SAR subject placebo .</brief_summary>
	<brief_title>Clinical Trial STAHIST Seasonal Allergic Rhinitis ( SAR ) Subjects</brief_title>
	<detailed_description>This double-blind , placebo-controlled study evaluate efficacy safety STAHIST vs. placebo 2-week period 100 study subject history SAR least two year . The study take place two site , Louisville , KY South Bend , IN . SAR symptom score compare include : nasal congestion , rhinorrhea , nasal itching , sneeze , post-nasal drip .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>1 . Males females ethnic group 18 60 year age . 2 . History moderate severe SAR least two year . 3 . Subjects ' symptom result irritation sinus , nasal upper respiratory tract tissue include five symptom th focus study : nasal congestion , rhinorrhea , nasal itching , sneeze , postnasal drip . Subjects must TSS baseline score least 8 S5 Subject Diary . 4 . Prior study drug administration , subject ' good health confirm medical history physical examination , include pregnancy test ( urine dip ) study inception . 5 . Allergic hypersensitivity confirm physician well establish patient medical history . 6 . Subject 's compliance requisite runin period subject confirm investigator/designee . 1 . Pregnancy lactation . 2 . Immunotherapy unless stable maintenance dose . 3 . Presence medical condition might interfere treatment evaluation require change therapy include limited high blood pressure urinary retention problem . 4 . Alcohol dependence . 5 . Use investigational drug previous month . 6 . Subjects present asthma require corticosteroid treatment . 7 . Subjects multiple drug allergy . 8 . Subjects know idiosyncratic reaction ingredient IMP ( STAHIST ) . 9 . Subject participate clinical study . 10 . Subject unable meet washout requirement . 11 . Subject clinically significant abnormal vital sign laboratory value preclude participation . 12 . Subject family relationship sponsor , investigator , staff sponsor investigator . 13 . A URI within 4 week study inception . 14 . Subjects take beta blocker trycyclic antidepressant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Phase 2</keyword>
	<keyword>SAR</keyword>
	<keyword>STAHIST</keyword>
</DOC>